Skip to main content Accessibility help
×
Home
  • Print publication year: 2020
  • Online publication date: July 2020

Chapter 17 - Infectious Conditions and the Immune System in Elders

Summary

The association of aging with an increased susceptibility to and mortality from infection has been observed since ancient times [1]. There are a large number of organ-specific physiological changes associated with aging that increase infection risk, including urogenital changes, weakened cough reflex, endocrinological changes, thinning skin, impaired circulatory function, and sarcopenia, as well as general issues such as malnutrition and increased malignancies

Related content

Powered by UNSILO
1.Yoshikawa, T. T. Perspective: aging and infectious diseases: past, present, and future. Journal of Infectious Diseases. 1997;176(4):1053–7.
2.El Chakhtoura, N. G., Bonomo, R. A., Jump, R. L. P.. Influence of aging and environment on presentation of infection in older adults. Infectious Disease Clinics of North America. 2017;31(4):593608.
3.Donahue, J. G., Choo, P. W., Manson, J. E., Platt, R.. The incidence of herpes zoster. Archives of Internal Medicine. 1995;155(15):1605–9.
4.Bavishi, C., Dupont, H. L.. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimentary Pharmacology & Therapeutics. 2011;34(11–12):1269–81.
5.Klein, N. C., Go, C. H., Cunha, B. A.. Infections associated with steroid use. Infectious Disease Clinics of North America. 2001;15(2):423–32, viii.
6.Furuno, J. P., Shurland, S. M., Zhan, M., et al. Comparison of the methicillin-resistant Staphylococcus aureus acquisition among rehabilitation and nursing home residents. Infection Control and Hospital Epidemiology. 2011;32(3):244–9.
7.Flannery, E. L., Wang, L., Zollner, S., et al. Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan. Clinical Infectious Diseases. 2011;53(12):1215–22.
8.Rodriguez, C., Korsak, N., Taminiau, B., et al. Clostridium difficile infection in elderly nursing home residents. Anaerobe. 2014;30:184–7.
9.Lindsay, L., Wolter, J., De Coster, I., Van Damme, P., Verstraeten, T.. A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review. BMC Infectious Diseases. 2015;15:425.
10.Rainwater-Lovett, K., Chun, K., Lessler, J.. Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review. Influenza and Other Respiratory Viruses. 2014;8(1):7482.
11.Mitchell, S. L., Shaffer, M. L., Loeb, M. B., et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Internal Medicine. 2014;174(10):1660–7.
12.Geiger, H., Rudolph, K. L.. Aging in the lympho-hematopoietic stem cell compartment. Trends in Immunology. 2009;30(7):360–5.
13.Ventura, M. T., Casciaro, M., Gangemi, S., Buquicchio, R.. Immunosenescence in aging: between immune cells depletion and cytokines up-regulation. Clinical and Molecular Allergy. 2017;15:21.
14.Stiasny, K., Aberle, J. H., Keller, M., Grubeck-Loebenstein, B., Heinz, F. X.. Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis. PLoS One. 2012;7(3):e34145.
15.Shaw, A. C., Joshi, S., Greenwood, H., Panda, A., Lord, J. M.. Aging of the innate immune system. Current Opinion in Immunology. 2010;22(4):507–13.
16.Fuentes, E., Fuentes, M., Alarcon, M., Palomo, I.. Immune system dysfunction in the elderly. Anais da Academia Brasileira de Ciencias. 2017;89(1):285–99.
17.Linehan, E., Fitzgerald, D. C.. Ageing and the immune system: focus on macrophages. European Journal of Microbiology & Immunology. 2015;5(1):1424.
18.Gupta, S. Role of dendritic cells in innate and adaptive immune response in human aging. Experimental Gerontology. 2014;54:4752.
19.Ponnappan, S., Ponnappan, U.. Aging and immune function: molecular mechanisms to interventions. Antioxidants & Redox Signaling. 2011;14(8):1551–85.
20.Shaw, A. C., Panda, A., Joshi, S. R., et al. Dysregulation of human Toll-like receptor function in aging. Ageing Research Reviews. 2011;10(3):346–53.
21.Fried, L. P., Tangen, C. M., Walston, J., et al. Frailty in older adults: evidence for a phenotype. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2001;56(3):M146–56.
22.Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., Rockwood, K.. Frailty in elderly people. Lancet. 2013;381(9868):752–62.
23.Hubbard, R. E., O’Mahony, M. S., Savva, G. M., Calver, B. L., Woodhouse, K. W.. Inflammation and frailty measures in older people. Journal of Cellular and Molecular Medicine. 2009;13(9b):3103–9.
24.Qu, T., Yang, H., Walston, J. D., Fedarko, N. S., Leng, S. X.. Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine. 2009;46(3):319–24.
25.Qu, T., Walston, J. D., Yang, H., et al. Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults. Mechanisms of Ageing and Development. 2009;130(3):161–6.
26.Semba, R. D., Margolick, J. B., Leng, S., et al. T cell subsets and mortality in older community-dwelling women. Experimental Gerontology. 2005;40(1–2):81–7.
27.van den Biggelaar, A. H., Huizinga, T. W., de Craen, A. J., et al. Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Experimental Gerontology. 2004;39(9):1407–14.
28.Girard, T. D., Opal, S. M., Ely, E. W.. Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clinical Infectious Diseases. 2005;40(5):719–27.
29.Krabbe, K. S., Bruunsgaard, H., Qvist, J., et al. Hypotension during endotoxemia in aged humans. European Journal of Anaesthesiology. 2001;18(9):572–5.
30.Thomasini, R. L., Pereira, D. S., Pereira, F. S. M., et al. Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women. PLoS One. 2017;12(7):e0180841.
31.Norman, D. C. Fever in the elderly. Clinical Infectious Diseases. 2000;31(1):148–51.
32.Pfitzenmeyer, P., Decrey, H., Auckenthaler, R., Michel, J. P.. Predicting bacteremia in older patients. Journal of the American Geriatrics Society. 1995;43(3):230–5.
33.Waalen, J., Buxbaum, J. N.. Is older colder or colder older? The association of age with body temperature in 18,630 individuals. Journals of Gerontology: Series A. 2011;66A(5):487–92.
34.Flournoy, D. J., Bernard, M. A.. Problems in diagnosing infections in the elderly. Journal of the National Medical Association. 1993;85(11):835–40.
35.Gleckman, R., Hibert, D.. Afebrile bacteremia. A phenomenon in geriatric patients. JAMA. 1982;248(12):1478–81.
36.Hepper, H. J., Sieber, C., Walger, P., Bahrmann, P., Singler, K.. Infections in the elderly. Critical Care Clinics. 2013;29(3):757–74.
37.Martin, G. S., Mannino, D. M., Moss, M.. The effect of age on the development and outcome of adult sepsis. Critical Care Medicine. 2006;34(1):1521.
38.ATAGI. The Australian Immunisation Handbook, 10th edn (2017 update). Canberra: Australian Government Department of Health; 2017.
39.Lefebvre, J. S., Haynes, L.. Vaccine strategies to enhance immune responses in the aged. Current Opinion in Immunology. 2013;25(4):523–8.
40.Wendelboe, A. M., Grafe, C., McCumber, M., Anderson, M. P.. Inducing herd immunity against seasonal influenza in long-term care facilities through employee vaccination coverage: a transmission dynamics model. Computational and Mathematical Methods in Medicine. 2015;2015:178247.
41.Stuart, R. L., Marshall, C., Orr, E., et al. Survey of infection control and antimicrobial stewardship practices in Australian residential aged-care facilities. Internal Medicine Journal. 2015;45(5):576–80.
42.Sogaard, M., Schonheyder, H. C., Riis, A., Sorensen, H. T., Norgaard, M.. Short-term mortality in relation to age and comorbidity in older adults with community-acquired bacteremia: a population-based cohort study. Journal of the American Geriatrics Society. 2008;56(9):1593–600.
43.Khayr, W. F., Carmichael, M. J., Dubanowich, C. S., Latif, R. H.. Epidemiology of bacteremia in the geriatric population. American Journal of Therapeutics. 2003;10(2):127–31.
44.Whitelaw, D. A., Rayner, B. L., Willcox, P. A.. Community-acquired bacteremia in the elderly: a prospective study of 121 cases. Journal of the American Geriatrics Society. 1992;40(10):9961000.
45.Caterino, J. M. Evaluation and management of geriatric infections in the emergency department. Emergency Medicine Clinics of North America. 2008;26(2):319–43, viii.
46.Chassagne, P., Perol, M. B., Doucet, J., et al. Is presentation of bacteremia in the elderly the same as in younger patients? American Journal of Medicine. 1996;100(1):6570.
47.Fontanarosa, P. B., Kaeberlein, F. J., Gerson, L. W., Thomson, R. B.. Difficulty in predicting bacteremia in elderly emergency patients. Annals of Emergency Medicine. 1992;21(7):842–8.
48.Bin Abdulhak, A. A., Baddour, L. M., Erwin, P. J., et al. Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Global Heart. 2014;9(1):131–43.
49.Slipczuk, L., Codolosa, J. N., Davila, C. D., et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665.
50.Crossley, K. B., Peterson, P. K.. Infections in the elderly. In Bennett, J. E., Dolin, R., Blaser, M. J., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn, Vol 2. Philadelphia: Elsevier Saunders; 2015. pp. 3459–65.e3.
51.Tleyjeh, I. M., Steckelberg, J. M., Murad, H. S., et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005;293(24):3022–8.
52.Terpening, M. S., Buggy, B. P., Kauffman, C. A.. Infective endocarditis: clinical features in young and elderly patients. American Journal of Medicine. 1987;83(4):626–34.
53.Di Salvo, G., Thuny, F., Rosenberg, V., et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. European Heart Journal. 2003;24(17):1576–83.
54.Barrau, K., Boulamery, A., Imbert, G., et al. Causative organisms of infective endocarditis according to host status. Clinical Microbiology and Infection. 2004;10(4):302–8.
55.Foxman, B., Brown, P.. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infectious Disease Clinics of North America. 2003;17(2):227–41.
56.Nicolle, L. E. Urinary tract infections in the older adult. Clinics in Geriatric Medicine. 2016;32(3):523–38.
57.D’Agata, E., Loeb, M. B., Mitchell, S. L.. Challenges assessing nursing home residents with advanced dementia for suspected urinary tract infections. Journal of the American Geriatrics Society. 2013;61(1):62–6.
58.De Vecchi, E., Sitia, S., Romano, C. L., Ricci, C., Mattina, R., Drago, L.. Aetiology and antibiotic resistance patterns of urinary tract infections in the elderly: a 6-month study. Journal of Medical Microbiology. 2013;62(Pt 6):859–63.
59.Hooton, T. M., Bradley, S. F., Cardenas, D. D., et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clinical Infectious Diseases. 2010;50(5):625–63.
60.Lee, E. A., Malatt, C.. Making the hospital safer for older adult patients: a focus on the indwelling urinary catheter. Permanente Journal. 2011;15(1):4952.
61.Miller, R. S., Norris, P. R., Jenkins, J. M., et al. Systems initiatives reduce healthcare-associated infections: a study of 22,928 device days in a single trauma unit. Journal of Trauma. 2010;68(1):2331.
62.Woodford, H. J., Graham, C., Meda, M., Miciuleviciene, J.. Bacteremic urinary tract infection in hospitalized older patients: are any currently available diagnostic criteria sensitive enough? Journal of the American Geriatrics Society. 2011;59(3):567–8.
63.Tal, S., Guller, V., Levi, S., et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. Journal of Infection. 2005;50(4):296305.
64.Boyd, L. B., Atmar, R. L., Randall, G. L., et al. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infectious Diseases. 2008;8:4.
65.Colodner, R., Kometiani, I., Chazan, B., Raz, R.. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection. 2008;36(1):41–5.
66.Tinelli, M., Cataldo, M. A., Mantengoli, E., et al. Epidemiology and genetic characteristics of extended-spectrum beta-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. Journal of Antimicrobial Chemotherapy. 2012;67(12):2982–7.
67.Gopal Rao, G., Patel, M.. Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era. Journal of Antimicrobial Chemotherapy. 2009;63(1):56.
68.Marrie, T. J. Epidemiology of community-acquired pneumonia in the elderly. Seminars in Respiratory Infections. 1990;5(4):260–8.
69.Marrie, T. J. Pneumonia in the long-term-care facility. Infection Control and Hospital Epidemiology. 2002;23(3):159–64.
70.Conte, H. A., Chen, Y. T., Mehal, W., Scinto, J. D., Quagliarello, V. J.. A prognostic rule for elderly patients admitted with community-acquired pneumonia. American Journal of Medicine. 1999;106(1):20–8.
71.Rozzini, R., Trabucchi, M.. Pneumonia and mortality beyond hospital discharge in elderly patients. Chest. 2011;139(2):473–4.
72.Kikuchi, R., Watabe, N., Konno, T., et al. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. American Journal of Respiratory and Critical Care Medicine. 1994;150(1):251–3.
73.Janssens, J. P., Krause, K. H.. Pneumonia in the very old. Lancet Infectious Diseases. 2004;4(2):112–24.
74.Kupronis, B. A., Richards, C. L., Whitney, C. G.. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. Journal of the American Geriatrics Society. 2003;51(11):1520–5.
75.Falsey, A. R., Walsh, E. E.. Viral pneumonia in older adults. Clinical Infectious Diseases 2006;42(4):518–24.
76.Charles, P. G., Whitby, M., Fuller, A. J., et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clinical Infectious Diseases. 2008;46(10):1513–21.
77.Johnstone, J., Majumdar, S. R., Fox, J. D., Marrie, T. J.. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest. 2008;134(6):1141–8.
78.Te Wierik, M. J., Nguyen, D. T., Beersma, M. F., Thijsen, S. F., Heemstra, K. A.. An outbreak of severe respiratory tract infection caused by human metapneumovirus in a residential care facility for elderly in Utrecht, the Netherlands, January to March 2010. European Communicable Disease Bulletin. 2012;17(13):pii: 20132.
79.Troy, C. J., Peeling, R. W., Ellis, A. G., et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA. 1997;277(15):1214–8.
80.Saviteer, S. M., Samsa, G. P., Rutala, W. A.. Nosocomial infections in the elderly. Increased risk per hospital day. American Journal of Medicine. 1988;84(4):661–6.
81.Marrie, T. J., Haldane, E. V., Faulkner, R. S., Durant, H., Kwan, C.. Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? Journal of the American Geriatrics Society. 1985;33(10):671–80.
82.Finkelstein, M. S., Petkun, W. M., Freedman, M. L., Antopol, S. C.. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. Journal of the American Geriatrics Society. 1983;31(1):1927.
83.Harper, C., Newton, P.. Clinical aspects of pneumonia in the elderly veteran. Journal of the American Geriatrics Society. 1989;37(9):867–72.
84.Johnson, J. C., Jayadevappa, R., Baccash, P. D., Taylor, L.. Non-specific presentation of pneumonia in hospitalized older people: age effect or dementia? Journal of the American Geriatrics Society. 2000;48(10):1316–20.
85.van Duin, D. Diagnostic challenges and opportunities in older adults with infectious diseases. Clinical Infectious Diseases. 2012;54(7):973–8.
86.Laube, S., Farrell, A. M.. Bacterial skin infections in the elderly: diagnosis and treatment. Drugs & Aging. 2002;19(5):331–42.
87.Nanduri, S. A., Metcalf, B. J., Arwady, M. A., et al. Prolonged and large outbreak of invasive group A Streptococcus disease within a nursing home: repeated intrafacility transmission of a single strain. Clinical Microbiology and Infection. 2019;25(2):248.e1–248.e7.
88.High, K. P., Jordan, H. T., Richards, J. C. L., et al. Group A streptococcal disease in long-term care facilities: descriptive epidemiology and potential control measures. Clinical Infectious Diseases. 2007;45(6):742–52.
89.Kothari, N. J., Morin, C. A., Glennen, A., et al. Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003–2007. Emerging Infectious Diseases. 2009;15(8):1279–81.
90.Anderson, D. J., Kaye, K. S.. Skin and soft tissue infections in older adults. Clinics in Geriatric Medicine. 2007;23(3):595613, vii.
91.Reddy, M., Gill, S. S., Rochon, P. A.. Preventing pressure ulcers: a systematic review. JAMA. 2006;296(8):974–84.
92.Bansal, C., Scott, R., Stewart, D., Cockerell, C. J.. Decubitus ulcers: a review of the literature. International Journal of Dermatology. 2005;44(10):805–10.
93.Livesley, N. J., Chow, A. W.. Infected pressure ulcers in elderly individuals. Clinical Infectious Diseases. 2002;35(11):1390–6.
94.Margolis, D. J., Bilker, W., Knauss, J., Baumgarten, M., Strom, B. L.. The incidence and prevalence of pressure ulcers among elderly patients in general medical practice. Annals of Epidemiology. 2002;12(5):321–5.
95.Pettersson, E., Vernby, A., Molstad, S., Lundborg, C. S.. Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scandinavian Journal of Infectious Diseases. 2008;40(5):393–8.
96.Jaul, E. Assessment and management of pressure ulcers in the elderly: current strategies. Drugs & Aging. 2010;27(4):311–25.
97.White-Chu, E. F., Flock, P., Struck, B., Aronson, L.. Pressure ulcers in long-term care. Clinics in Geriatric Medicine. 2011;27(2):241–58.
98.Engemann, J. J., Carmeli, Y., Cosgrove, S. E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clinical Infectious Diseases. 2003;36(5):592–8.
99.Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., Jarvis, W. R.. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infection Control and Hospital Epidemiology. 1999;20(4):250–78; quiz 79–80.
100.McGarry, S. A., Engemann, J. J., Schmader, K., Sexton, D. J., Kaye, K. S.. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infection Control and Hospital Epidemiology. 2004;25(6):461–7.
101.Gorse, G. J., Thrupp, L. D., Nudleman, K. L., et al. Bacterial meningitis in the elderly. Archives of Internal Medicine. 1984;144(8):1603–7.
102.Tunkel, A. R., van de Beek, D., Scheld, W. M.. Acute meningitis. In Bennett, J. E., Dolin, R., Blaser, M. J., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn, Vol 1. Philadelphia: Elsevier Saunders; 2015. pp. 1097–137.e10.
103.Brouwer, M. C. M. D., Thwaites, G. E. M. D., Tunkel, A. R. P., van de Beek, D. P.. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet. 2012;380(9854):1684–92.
104.Bennett, J. E. Chronic meningitis. In Bennett, J. E., Dolin, R., Blaser, M. J., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn, Vol 1. Philadelphia: Elsevier Saunders; 2015. pp. 1138–43.
105.Leber, A. L., Everhart, K., Balada-Llasat, J. M., et al. Multicenter evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. Journal of Clinical Microbiology. 2016;54(9):2251–61.
106.Tan, K., Patel, S., Gandhi, N.,et al. Burden of neuroinfectious diseases on the neurology service in a tertiary care center. Neurology. 2008;71(15):1160–6.
107.Glaser, C. A., Honarmand, S., Anderson, L. J., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clinical Infectious Diseases. 2006;43(12):1565–77.
108.Petersen, L. R., Marfin, A. A.. West Nile virus: a primer for the clinician. Annals of Internal Medicine. 2002;137(3):173–9.
109.Cardemil, C. V., Parashar, U. D., Hall, A. J.. Norovirus infection in older adults: epidemiology, risk factors, and opportunities for prevention and control. Infectious Disease Clinics of North America. 2017;31(4):839–70.
110.Teunis, P. F., Moe, C. L., Liu, P., et al. Norwalk virus: how infectious is it? Journal of Medical Virology. 2008;80(8):1468–76.
111.Trivedi, T. K., DeSalvo, T., Lee, L., et al. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009–2010. JAMA. 2012;308(16):1668–75.
112.Lessa, F. C., Mu, Y., Bamberg, W. M., et al. Burden of Clostridium difficile infection in the United States. New England Journal of Medicine. 2015;372(9):825–34.
113.Bartlett, J. G., Gerding, D. N.. Clinical recognition and diagnosis of Clostridium difficile infection. Clinical Infectious Diseases. 2008;46(Suppl 1):S12–8.
114.van den Berg, R. J., Bruijnesteijn van Coppenraet, L. S., Gerritsen, H. J., et al. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. Journal of Clinical Microbiology. 2005;43(10):5338–40.
115.Gerding, D. N., Young, V. B.. Clostridium difficile infection. In Bennett, J. E., Dolin, R., Blaser, M. J., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn, Vol 2. Philadelphia: Elsevier Saunders; 2015. pp. 2744–56.e3.
116.Podnos, Y. D., Jimenez, J. C., Wilson, S. E.. Intra-abdominal sepsis in elderly persons. Clinical Infectious Diseases. 2002;35(1):62–8.
117.Cooper, G. S., Shlaes, D. M., Salata, R. A.. Intraabdominal infection: differences in presentation and outcome between younger patients and the elderly. Clinical Infectious Diseases. 1994;19(1):146–8.
118.Sartelli, M., Catena, F., Ansaloni, L., et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World Journal of Emergency Surgery. 2012;7(1):36.
119.Berlin, A., Johanning, J. M.. Intraabdominal infections in older adults. Clinics in Geriatric Medicine. 2016;32(3):493507.
120.Lau, W. Y., Fan, S. T., Yiu, T. F., Chu, K. W., Lee, J. M.. Acute appendicitis in the elderly. Surgery, Gynecology & Obstetrics. 1985;161(2):157–60.
121.Watters, J. M., Blakslee, J. M., March, R. J., Redmond, M. L.. The influence of age on the severity of peritonitis. Canadian Journal of Surgery. 1996;39(2):142–6.
122.Soreide, K., Desserud, K. F.. Emergency surgery in the elderly: the balance between function, frailty, fatality and futility. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2015;23:10.
123.Golfieri, R., Cappelli, A.. Computed tomography-guided percutaneous abscess drainage in coloproctology: review of the literature. Techniques in Coloproctology. 2007;11(3):197208.
124.Salminen, P., Paajanen, H., Rautio, T., et al. Antibiotic therapy vs appendectomy for treatment of uncomplicated acute appendicitis: The APPAC Randomized Clinical Trial. JAMA. 2015;313(23):2340–8.
125.Haltmeier, T., Benjamin, E., Inaba, K., Lam, L., Demetriades, D.. Early versus delayed same-admission laparoscopic cholecystectomy for acute cholecystitis in elderly patients with comorbidities. Journal of Trauma and Acute Care Surgery. 2015;78(4):801–7.
126.Sawyer, R. G., Claridge, J. A., Nathens, A. B., et al. Trial of short-course antimicrobial therapy for intraabdominal infection. New England Journal of Medicine. 2015;372(21):19962005.
127.UNAIDS. HIV and aging: A special supplement to the UNAIDS report on the global AIDS epidemic 2013. 2013. www.unaids.org/sites/default/files/media_asset/20131101_JC2563_hiv-and-aging_en_0.pdf.
128.Centers for Disease Control and Prevention. HIV Surveillance Report, 2015; vol. 27. November 2016. www.cdc.gov/hiv/library/reports/hiv-surveillance.html (accessed October 31, 2019).
129.Hall, H. I., Song, R., Szwarcwald, C. L., Green, T.. Brief report: time from infection with the human immunodeficiency virus to diagnosis, United States. Journal of Acquired Immune Deficiency Syndromes. 2015;69(2):248–51.
130.Sabin, C. A., Smith, C. J., d’Arminio Monforte, A., et al. Response to combination antiretroviral therapy: variation by age. AIDS (London, England). 2008;22(12):1463–73.
131.Freiberg, M. S., Chang, C. C., Kuller, L. H., et al. HIV infection and the risk of acute myocardial infarction. JAMA Internal Medicine. 2013;173(8):614–22.
132.Scott, J., Goetz, M. B.. Human immunodeficiency virus/acquired immunodeficiency syndrome in older adults. Clinics in Geriatric Medicine. 2016;32(3):571–83.
133.Mocroft, A., Lundgren, J. D., Ross, M., et al. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Medicine. 2015;12(3):e1001809.
134.Yarchoan, R., Uldrick, T. S.. HIV-associated cancers and related diseases. New England Journal of Medicine. 2018;378(11):1029–41.
135.Robbins, H. A., Pfeiffer, R. M., Shiels, M. S., et al. Excess cancers among HIV-infected people in the United States. Journal of the National Cancer Institute. 2015;107(4):pii: dju503.
136.Greene, M., Covinsky, K. E., Valcour, V., et al. Geriatric syndromes in older HIV-infected adults. Journal of Acquired Immune Deficiency Syndromes. 2015;69(2):161–67.
137.World Health Organization (WHO). Global Hepatitis Report 2017. Geneva: WHO; 2017.
138.Carrion, A. F., Martin, P.. Viral hepatitis in the elderly. American Journal of Gastroenterology. 2012;107(5):691–7.
139.Chen, J. D., Yang, H. I., Iloeje, U. H., et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology. 2010;138(5):1747–54.
140.Chen, C. J., Yang, H. I., Su, J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):6573.
141.Yeo, W., Johnson, P. J.. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology (Baltimore, MD). 2006;43(2):209–20.
142.Yuen, M.-F., Chen, D.-S., Dusheiko, G. M., et al. Hepatitis B virus infection. Nature Reviews Disease Primers. 2018;4:18035.
143.Saab, S., Rheem, J., Sundaram, V.. Hepatitis C infection in the elderly. Digestive Diseases and Sciences. 2015;60(11):3170–80.
144.Thabut, D., Le Calvez, S., Thibault, V., et al. Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? American Journal of Gastroenterology. 2006;101(6):1260–7.
145.Minola, E., Prati, D., Suter, F., et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood. 2002;99(12):4588–91.
146.Tal, S., Guller, V., Gurevich, A.. Fever of unknown origin in older adults. Clinics in Geriatric Medicine. 2007;23(3):649–68, viii.
147.Cunha, B. A. Fever of unknown origin: clinical overview of classic and current concepts. Infectious Disease Clinics of North America. 2007;21(4):867915, vii.
148.Knockaert, D. C., Vanneste, L. J., Bobbaers, H. J.. Fever of unknown origin in elderly patients. Journal of the American Geriatrics Society. 1993;41(11):1187–92.
149.Roth, A. R., Basello, G. M.. Approach to the adult patient with fever of unknown origin. American Family Physician. 2003;68(11):2223–8.
150.Epperly, T. D., Moore, K. E., Harrover, J. D.. Polymyalgia rheumatica and temporal arthritis. American Family Physician. 2000;62(4):789–96, 801.
151.Cunha, B. A., Berbari, N.. Subacute thyroiditis (de Quervain’s) due to influenza A: presenting as fever of unknown origin (FUO). Heart & Lung. 2013;42(1):77–8.
152.Sorrell, T. C., Mitchell, D. H., Iredell, J. R., Chen, S. C.-A.. Nocardia species. In Bennett, J. E. Dolin, R., Blaser, M. J., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn, Vol 2. Philadelphia: Elsevier Saunders; 2015. pp. 2853–63.e3.
153.Lorber, B. Listeria monocytogenes. In Bennett, J. E. Dolin, R., Blaser, M. J., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn, Vol 2. Philadelphia: Elsevier Saunders; 2015. pp. 2383–90.e2.
154.Mylonakis, E., Hohmann, E. L., Calderwood, S. B.. Central nervous system infection with Listeria monocytogenes: 33 years’ experience at a general hospital and review of 776 episodes from the literature. Medicine. 1998;77(5):313–36.
155.Lorber, B. Listeriosis. Clinical Infectious Diseases. 1997;24(1):19;quiz 10–1.
156.Lim, S., Chung, D. R., Kim, Y. S., et al. Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter case-control study. Infection. 2017;45(1):6774.